Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NanoEcho Particle-1 MMUS for Rectal Cancer Staging
NCT06693375Phase 2Recruiting
- Sponsor
- NanoEcho
- Start
- Oct 2024
- Primary completion
- May 2026
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of ferumoxtran-10 in rectal cancer, sponsored by NanoEcho. Started Oct 2024; status: recruiting.
02
Drugs
ferumoxtran-10
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT06693375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06693375.